Navigation Links
Presence of certain antibodies signals healthier teeth and gums
Date:4/23/2008

ANN ARBOR, Mich.---Antibodies present in people with good oral health could become the first tool for dental professionals to assess a patient's probable response to periodontal disease treatments, say researchers at the University of Michigan.

The antibody is to a protein called HtpG, the bug that makes it is Porphyromonas gingivalis, an important pathogen in periodontal disease. The antibody also has potential as a vaccine candidate, according to Charles Shelburne, assistant research scientist at the U-M School of Dentistry.

Researchers discovered that the HtpG antibodies were present in much lower amounts in people with periodontal disease, and in much higher concentrations in those with healthier teeth and gums. Typically, antibodies are elevated in people with disease, because they help fight the disease.

"What has been seen in periodontal disease over the last 30-40 years is that patients with periodontal disease have higher levels of antibodies to the bacteria associated with periodontal disease, but what we know is that those antibodies aren't usually protective," said Dennis Lopatin, principal investigator and senior associate dean of the School of Dentistry. "It's like being vaccinated against the wrong strain of the flu. The healthy patient makes high levels of the antibodies but to the right part of the bug."

Not only were the HtpG antibodies present in higher amounts in people with healthier gums, those patients with the antibodies responded better to periodontal treatment, the researchers say.

"We're in a position now where we have a potential tool that gives insight as to how the patient will respond to treatment," Lopatin said. "In the United States we spend $8 billion to $12 billion a year caring for people with serious periodontal disease. From a public health standpoint, it's very important to identify those people who not only need therapy but will actually respond to a specific type of therapy
'/>"/>

Contact: Laura Bailey
baileylm@umich.edu
734-764-1552
University of Michigan
Source:Eurekalert

Page: 1 2

Related biology news :

1. Presence of gene mutation helps guide thyroid cancer treatment
2. EPFL Research Day 2008, in the presence of Al Gore
3. Uncertainty drives the evolution of cooperative breeding in birds
4. Bilberry extract -- can it help prevent certain cancers?
5. Certain diseases, birth defects may be linked to failure of protein recycling system
6. Managing uncertainty important in ecological balance: ASU researcher
7. Can certain metals repel sharks from fishing gear?
8. Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find
9. Cell response to stress signals predicts tumors in women with common pre-breast cancer
10. Surprise in the organic orchard -- a healthier worm in the apple
11. Alternative food networks connect ethical producers and consumers and can lead to healthier eating

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...els that repels grime and dirt? Expanded battery s...el Aviv University research, just published in Na...sembling peptides at the nano-scale level that cou... a few years. , Operating in the range of 100 na...en smaller, graduate student Lihi Adler-Abramovich...
(Date:12/3/2009)...nality change in warmer water, according to an int...ay make some species more aggressive. , Experime...lia,s Great Barrier Reef have shown for the first ...imid, or consistently bold, and that these individ...eratures rise. , A slight lift of just one or tw...
(Date:12/3/2009)...m the U.S. Department of Energy,s (DOE) Brookhaven...Indian Institute of Science has made a major step ...information in DNA that is necessary to carry out ...ished in the December 1, 2009 edition of Nature S... proteins responsible for interacting at specific ...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Folk Medicine Therapy May Prevent Alcoholic Relapse 54302 1Folk Medicine Therapy May Prevent Alcoholic Relapse 54302 2maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition 54299 1maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition 54299 2maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition 54299 3Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 1Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 2Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 3Members of Over 71 Million U S Households Ignored by Universal Healthcare 54296 4
...f the 2006-2007 activities of UC San Diegos engine...y they recently took home the nations most outstan...oss fundraiser. , Youll find the detailed lesson ...ineering and science fundamentals to 75 fifth grad... find all kinds of information about the tutoring ...
...ajor role in an international scientific team that...ely related fruit fly species. As well has having ...tation to evolving immune systems -- the analysis ...on of each species., From the results of the resea... two papers published this week in the journal Nat...
...y of Idaho researchers are crossing academic and g...ses against Staphylococcus aureus bacteria and oth... effort is to create much faster and more accurate...otic methicillin, formally known as methicillin-re...rough detection technologies are already in hand i...
Other Biology News:UC-San Diego Engineering Honor Society wins most outstanding chapter award 2International team compares 12 fruit fly genomes 2International team compares 12 fruit fly genomes 3Developing kryptonite for Superbug 2Developing kryptonite for Superbug 3Developing kryptonite for Superbug 4Developing kryptonite for Superbug 5
(Date:12/2/2009)...2 Reportlinker.com announces that ...atalogue: ,, Drug Discovery Technologies - A G... ,, http://www.reportlinker.com/p0164246/Drug-...-Trends--Opportunities.html ,, Drug discovery ...y pharmaceutical company,s business strategy. Ther...
(Date:12/2/2009)...c. 2 Peregrine Pharmaceu...etion of patient enrollment in a dose confirmation...ith relapsed glioblastoma multiforme (GBM), the de...d monoclonal antibody linked to a radioisotope bei... Cotara specifically targets cells at the center ...
(Date:12/2/2009)...therlands, December 2 Pepscan Hold...y focusing on protein mimicking,technology for the... that it,has appointed Wim E.M. Mol, Ph.D. as new ...e responsible for all of Pepscans corporate functi...tion of the company. He brings to,Pepscan more tha...
(Date:12/2/2009)... 2 S*BIO Pte Ltd today announced d..., SB1518, at The American Society of Hematology 51..., Data will be presented on the clinical result... detailing its safety, tolerability and pharmacoki...ls ranging from 100 to 600 mg. These doses were ad...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...evelopment, Biomarker Identification ..., Oct. 10 MultiCell,Technologies, Inc. (OTC Bulle...ve license and technology purchase agreement with ... Company,s Fa2N-4 immortalized,adult human liver c...and has agreed to purchase,certain inventory and e...
...herapeutics Corporation (Nasdaq: TARG ) today ann...of 5,750,000 shares of its common stock at a price...res are being offered by,Targanta. Targanta has gr...ase up to an additional 862,500 shares of common s...ing discounts and commissions, to cover,over-allot...
...efits of Unsaturated Fatty Acids in ... 10 Amarin Corporation plc,(NASDAQ: AMRN ) today...development strategy to capitalize on the known th...ardiovascular disease. Amarin plans to utilize,its...e to develop a series,of products targeting the va...
Other Biology Technology:MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated 2MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated 3Targanta Therapeutics Announces Pricing of its Initial Public Offering 2Amarin Announces Initiation of Cardiovascular Development Strategy 2Amarin Announces Initiation of Cardiovascular Development Strategy 3Amarin Announces Initiation of Cardiovascular Development Strategy 4Amarin Announces Initiation of Cardiovascular Development Strategy 5
Chaps Cell Extract Buffer (10X) from Cell Signaling Technology
UltraClean Microbial DNA Isolation Kit from Mo Bio Laboratories, Inc.
Custom Oligo Assay Single Locus 1920 samples from Illumina
Anti-Human L-Ficolin Monoclonal Antibody, Unconjugated, Clone GN4 from Cell Sciences
Biology Products: